Invited Talks & Academic Lectures
The Stanley P. Reimann Award Lecture, The Fox Chase Cancer Center, Philadelphia, PA (June 2025).
Precision Ophthalmology, Columbia University, New York, NY (June 2025).
Annual Molecular Pathobiology Innovative Research Symposium (AMPIRS), NYU, New York, NY (May 2025).
Podcast & Video Interviews
2024
Podcast Interview—Alain Elkann Interviews. Episode: Educating the Immune Response. Dr. Andrea Califano discusses the CZ Biohub’s goal to reengineer the immune system for early detection and treatment of major diseases. Through interdisciplinary collaboration and AI-driven research, the initiative aims to develop universal, cell-based therapies that could make diseases like cancer and Alzheimer's manageable within the next decade. Listen on YouTube
Podcast Interview—Biofrontier Files. Episode 18: Interview with Dr. Andrea Califano. Departing from the ongoing series on a summer research program, the episode presents Dr. Califano’s insights on topics such as ARACNe and systems biology, alongside valuable guidance for aspiring scientists. Listen on YouTube
2023
Panel Discussion — Dr. Califano discusses the creation of a new scientific institute in NY to Engineer Immune Cells | CZI, Columbia, Rockefeller and Yale CZ Biohub New York (10.18.2023)(link)
YouTube Interview— STAT in NYC: A Look Ahead at Biotech in 2024. Episode: How Bioengineered Cells Could Revolutionize Cancer Care. At the December 2023 STAT in NYC event, Andrea Califano, President of CZ Biohub New York, discussed the initiative’s focus on engineering immune cells for early disease detection and treatment. In conversation with STAT's Nicholas St. Fleur, Califano outlined the Biohub’s emphasis on immunology and its plans for future development. Listen on YouTube
Podcast Interview—Columbia University BioWorks. Episode: Identifying the Master Regulators of Cancer in Academia and Biotech. Dr. Califano talks about his research on identifying checkpoints within cancer cells. Through algorithms and experimental verification, the Califano Lab can find specific proteins that are crucial for tumor progression, revealing useful therapeutic targets. As the co-founder of DarwinHealth, Dr. Califano explains how his research is translated into New York City’s biotech scene, Listen on Spotify
2022
Podcast Interview—Columbia Invents. Dr. Califano speaks about mapping master regulators, entrepreneurial efforts like DarwinHealth, and collaborative work with industry partners to repurpose compounds in cancer care. Listen on YouTube
2021
Podcast Interview—People Behind the Science: “Translating Gene Expression Experiments into Therapies for Human Disease.” Focus on techniques to reconstruct regulatory systems and their role in therapeutic development. Listen on YouTube
2020
Podcast Interview—Lab in the Time of Coronavirus: “Research, Going Viral” (The Columbia / Zuckerman Institute Podcast). During the COVID-19 pandemic, Columbia University’s weekly virtual COVID-19 Symposium—co-organized and regularly featured by Dr. Andrea Califano—brought together global experts to rapidly share emerging research, fostering unprecedented real-time collaboration and knowledge exchange. Listen on YouTube
2019
Feature Interview —Systems Biology with Andrea Califano (BioTechniques). A “Behind the Technique” video interview discussing systems biology, cancer research, and precision medicine. Listen on YouTube
Press & Media Coverage
2025
Feature News— “New CZI AI Model Could Help Scientists Pinpoint Signs of Cancer Cells”. A news release from Columbia University about the development of GREmLN, an AI-based model created by a research team led by Dr. Califano. GREmLN is part of a broader class of biological models designed to predict and elucidate cellular functions, aligning with the institution’s mission to advance the prevention, management, and treatment of all diseases. Read article
2024
Feature News— “CZI, State, and City Leaders Launch Chan Zuckerberg Biohub New York, a tri-state initiative led by Dr. Califano”. The Chan Zuckerberg Initiative (CZI), and representatives from Columbia University, The Rockefeller University, and Yale University gathered to celebrate progress in their mission to bioengineer immune cells for the early detection and treatment of diseases. Read article.
2023
Feature News — “Harnessing the immune system to detect and eradicate diseases in their earliest states”. A Columbia University news release, about the mission of the Chan Zuckerberg Biohub NY. Read Interview
Feature News — Global Health Today: “Targeting cancer's hidden masters: A new approach to cancer treatment”. As featured in Global Health Today, Dr. Andrea Califano’s team at Columbia University has introduced a novel approach to cancer treatment that targets "master regulators"—core proteins controlling tumor growth—rather than specific genetic mutations. Using computational and gene expression analysis, this strategy offers a promising path toward more personalized and broadly effective cancer therapies. Listen on YouTube.
2022
NIH VideoCast— The NIH Director’s Wednesday Afternoon Lecture Series: “Elucidation and Pharmacological Targeting of Cellular Dependencies at the Single Cell Level” featuring Dr. Califano’s work at Columbia University. Watch the Series.